Because they don't plan on shorting the stock.
Scenario 1: You buy 1,000 shares of a stock at $2/share and it steadily climbs over the next 2 years to $10/share. Profit: $8,000
Scenario 2: You buy 500 shares of a stock at $2/share and it drops to $1/share so you buy 500 more shares. At the end of 2 years the stock is worth $10/share. Profit: $8,500
I'll take scenario 2 any day of the week.
I purchased most of my shares at $0.30 and added some at $0.76. During that time Oncosec has done nothing but prove the value with all of their catalysts. Now at $0.48, to me it's just a great buying opportunity and nothing more. If I was averaged in at $0.60 I'd probably more frustrated but at the end of the day it's all about where it will be down the road.
News 
Market Data 
Discover 
